文献速递系统性红斑狼疮其他结缔组织病类风湿关节炎

罕见HEp-2细胞免疫荧光模式在无特异性抗体时识别不同自身免疫病:西班牙多中心研究

Rare immunofluorescence patterns of autoantibodies on HEp-2 cells defined by ICAP identify different autoimmune diseases in the absence of associated specificities: a Spanish multicentre study.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该回顾性研究纳入608例经HEp-2细胞间接免疫荧光确认罕见ANA模式的器官特异性和非器官特异性自身免疫病患者,随访至少2年。核型在SLE和SS更常见,胞质型在SSc和炎性肌炎更高,AC-26核型以SLE、SS和RA为主,OSAD中AC-6与Sp-100抗体相关见于原发性胆汁性胆管炎。

要点

  • 核型ANA模式在SLE和SS患者中更常见,胞质型在SSc和炎性肌炎中显著更高。
  • AC-26核型在非器官特异性患者中最常见于SLE、SS和RA。
  • 器官特异性患者无优势模式,仅AC-6因Sp-100抗体见于原发性胆汁性胆管炎。

核心结论

  • 罕见ANA荧光模式可能是无疾病相关特异性抗体的唯一发现,并可提示自身免疫病可能。

研究设计与样本

  • 西班牙欧洲自身抗体标准化倡议实验室常规实践中开展的多中心观察性回顾性研究,纳入608例器官特异性或非器官特异性自身免疫病患者,均经HEp-2细胞间接免疫荧光确认罕见ANA模式,要求至少2年随访且临床资料可用。

主要发现

  • 核型模式在SLE(P=0.001)和SS(P=0.001)中更常见,胞质型模式在SSc(P=0.022)和炎性肌炎(P=0.016)中显著更高。
  • 有丝分裂型模式未显示对特定疾病的偏好,其中62.7%对应核有丝分裂器模式(AC-26)。
  • AC-26模式患者中最常见的非器官特异性自身免疫病为SLE(28.6%)、SS(11.9%)和RA(11.9%)。
  • 胞质HEp-2间接免疫荧光模式在两组患者中分布均等。
  • 器官特异性患者中无 predominant 模式,仅原发性胆汁性胆管炎中AC-6因Sp-100抗体而突出(P<0.001)。

关键数值与推荐

  • 核型模式与SLE(P=0.001)和SS(P=0.001)相关,胞质型模式与SSc(P=0.022)和炎性肌炎(P=0.016)相关。
  • 有丝分裂型模式中62.7%为AC-26模式。
  • AC-26模式患者中SLE占28.6%、SS占11.9%、RA占11.9%。
  • 原发性胆汁性胆管炎中AC-6模式与Sp-100抗体相关(P<0.001)。

临床怎么用

  • 对HEp-2细胞间接免疫荧光检测到罕见ANA模式但无已知特异性抗体时,应结合核型或胞质型模式及临床特征警惕潜在自身免疫病。
  • 核型模式提示需关注SLE和SS,胞质型模式提示需关注SSc和炎性肌炎,AC-26模式尤其需评估SLE、SS和RA。
  • 器官特异性患者出现AC-6模式时应考虑原发性胆汁性胆管炎及Sp-100抗体检测。

局限性

  • 本研究为回顾性观察性研究,仅纳入西班牙多中心实验室常规实践中随访至少2年且有临床资料的患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: ANA are the most extensively used test for the diagnosis of systemic autoimmune diseases. However, testing by indirect immunofluorescence assays (IIFAs) on HEp-2 cells, the gold standard test, is time-consuming and needs expertise. Thus there is a trend to replace it with other automated solid-phase assays directed against specific ANA. Nonetheless, the Hep-2 cell is an autoantigen array and ANA have been classified into 29 types, some of them with no clear association with a specificity to be detected. It is especially in these uncommon patterns where no clinical relationship is found and no antigenic specificity is detected. Here we retrospectively collected clinical data from patients with confirmed uncommon HEp-2 IIFA patterns to search for an associated clinical condition. METHODS: We conducted an observational retrospective study including 608 patients with organ-specific and non-organ-specific autoimmune diseases (OSADs and NOSADs, respectively) with a confirmed rare pattern of ANA detected by IIFA on HEp-2 cells in the routine practice of the Spanish European Autoantibodies Standardization Initiative laboratories. Inclusion criteria are the existence of a minimum follow-up of 2 years and the availability of clinical data. RESULTS: Nuclear patterns were more frequent in SLE (P = 0.001) and SS (P = 0.001), whereas the cytoplasmic ones were significantly higher in SSc (P = 0.022) and inflammatory myositis (P = 0.016). Mitotic patterns did not show any preferences for a specific disease and 62.7% of them corresponded to the nuclear mitotic apparatus pattern (AC-26). The most frequent NOSADs in patients with the AC-26 pattern were SLE (28.6%), SS (11.9%) and RA (11.9%). The cytoplasmic HEp-2 IIFA patterns were equally distributed in both groups of patients. In the OSAD patients there was no predominant pattern, except for AC-6 in primary biliary cholangitis due to Sp-100 antibodies (P < 0.001). CONCLUSION: Detection of infrequent ANA might be a unique finding with no disease-associated specificities and could lead to the suspicion of an autoimmune disease.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Irure-Ventura J, Rodríguez C, Vergara-Prieto E, et al. Rare immunofluorescence patterns of autoantibodies on HEp-2 cells defined by ICAP identify different autoimmune diseases in the absence of associated specificities: a Spanish multicentre study. Rheumatology (Oxford). 2021. PMID: 33437990. doi:10.1093/rheumatology/keaa831

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。